Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection
Clinical trial NCT04355793 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04355793
- Sponsor
- Incyte Corporation
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.